Innogenetics Stocks List
Symbol | Grade | Name | % Change | |
---|---|---|---|---|
MYNZ | F | Mainz Biomed B.V. | -4.76 | |
LH | D | Laboratory Corporation of America Holdings | -0.09 |
Related Industries: Diagnostics & Research
Symbol | Grade | Name | Weight | |
---|---|---|---|---|
CAMX | A | The Advisors? Inner Circle Fund Cambiar Aggressive Value ETF | 4.42 | |
IHF | D | iShares U.S. Health Care Providers ETF | 2.94 | |
GSIG | A | Goldman Sachs Access Investment Grade Corporate 1-5 Year Bond ETF | 0.43 | |
IMCV | B | iShares Morningstar Mid-Cap Value ETF | 0.34 | |
IYH | C | iShares U.S. Healthcare ETF | 0.32 |
Compare ETFs
Related Industries:
Diagnostics & Research
- Innogenetics
Innogenetics N.V. (now Fujirebio Europe N.V.) is an international in vitro diagnostics (IVD) company, with headquarters in Ghent, Belgium. The company develops and markets IVD testing solutions from specialized manual testing to fully automated routine testing that cover areas such as infectious diseases, oncology, genetic testing, thyroid, fertility, tissue typing, neurodegeneration and bone. The company was acquired in September 2010 by Japanese Fujirebio Inc., part of Miraca Holdings Inc., and changed name to Fujirebio Europe on October 1, 2013. The CEO of Fujirebio Europe N.V. is Christiaan De Wilde.
Popular Now
Recent Comments
- LillyMilly1 on LILM
- LillyMilly1 on LILM
- TraderMike on RYDE what a RIDE!!! Holy Crap!
- Crunching_The_Market on RYDE what a RIDE!!! Holy Crap!
- LillyMilly1 on LILM
From the Blog
Featured Articles